These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23667900)

  • 1. Three-dimensional cultures modeling premalignant progression of human breast epithelial cells: role of cysteine cathepsins.
    Mullins SR; Sameni M; Blum G; Bogyo M; Sloane BF; Moin K
    Biol Chem; 2012 Dec; 393(12):1405-16. PubMed ID: 23667900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p21-Activated kinase 1 coordinates aberrant cell survival and pericellular proteolysis in a three-dimensional culture model for premalignant progression of human breast cancer.
    Li Q; Mullins SR; Sloane BF; Mattingly RR
    Neoplasia; 2008 Apr; 10(4):314-29. PubMed ID: 18392133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasion of ras-transformed breast epithelial cells depends on the proteolytic activity of cysteine and aspartic proteinases.
    Premzl A; Puizdar V; Zavasnik-Bergant V; Kopitar-Jerala N; Lah TT; Katunuma N; Sloane BF; Turk V; Kos J
    Biol Chem; 2001 May; 382(5):853-7. PubMed ID: 11517941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myoepithelial cell-specific expression of stefin A as a suppressor of early breast cancer invasion.
    Duivenvoorden HM; Rautela J; Edgington-Mitchell LE; Spurling A; Greening DW; Nowell CJ; Molloy TJ; Robbins E; Brockwell NK; Lee CS; Chen M; Holliday A; Selinger CI; Hu M; Britt KL; Stroud DA; Bogyo M; Möller A; Polyak K; Sloane BF; O'Toole SA; Parker BS
    J Pathol; 2017 Dec; 243(4):496-509. PubMed ID: 29086922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasiveness of transformed human breast epithelial cell lines is related to cathepsin B and inhibited by cysteine proteinase inhibitors.
    Bervar A; Zajc I; Sever N; Katunuma N; Sloane BF; Lah TT
    Biol Chem; 2003 Mar; 384(3):447-55. PubMed ID: 12715895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trial of the cysteine cathepsin inhibitor JPM-OEt on early and advanced mammary cancer stages in the MMTV-PyMT-transgenic mouse model.
    Schurigt U; Sevenich L; Vannier C; Gajda M; Schwinde A; Werner F; Stahl A; von Elverfeldt D; Becker AK; Bogyo M; Peters C; Reinheckel T
    Biol Chem; 2008 Aug; 389(8):1067-74. PubMed ID: 18710344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential cathepsin responses to inhibitor-induced feedback: E-64 and cystatin C elevate active cathepsin S and suppress active cathepsin L in breast cancer cells.
    Wilder CL; Walton C; Watson V; Stewart FAA; Johnson J; Peyton SR; Payne CK; Odero-Marah V; Platt MO
    Int J Biochem Cell Biol; 2016 Oct; 79():199-208. PubMed ID: 27592448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biochemical evaluation of benzoylbenzophenone thiosemicarbazone analogues as potent and selective inhibitors of cathepsin L.
    Parker EN; Song J; Kishore Kumar GD; Odutola SO; Chavarria GE; Charlton-Sevcik AK; Strecker TE; Barnes AL; Sudhan DR; Wittenborn TR; Siemann DW; Horsman MR; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem; 2015 Nov; 23(21):6974-92. PubMed ID: 26462052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the selective and non-selective cysteine protease inhibitors on the intracellular processing of interleukin 6 by HEPG2 cells.
    Peppard JV; Knap AK
    In Vitro Cell Dev Biol Anim; 1999 Sep; 35(8):459-64. PubMed ID: 10501085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postictal blockade of ischemic hippocampal neuronal death in primates using selective cathepsin inhibitors.
    Tsuchiya K; Kohda Y; Yoshida M; Zhao L; Ueno T; Yamashita J; Yoshioka T; Kominami E; Yamashima T
    Exp Neurol; 1999 Feb; 155(2):187-94. PubMed ID: 10072294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysosomal proteases as potential targets for the induction of apoptotic cell death in human neuroblastomas.
    Castino R; Pace D; Démoz M; Gargiulo M; Ariatta C; Raiteri E; Isidoro C
    Int J Cancer; 2002 Feb; 97(6):775-9. PubMed ID: 11857353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cells producing cathepsins D, B, and L in human breast carcinoma and their association with prognosis.
    Lah TT; Kalman E; Najjar D; Gorodetsky E; Brennan P; Somers R; Daskal I
    Hum Pathol; 2000 Feb; 31(2):149-60. PubMed ID: 10685628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathepsins B and L in synovial fluids from patients with rheumatoid arthritis and the effect of cathepsin B on the activation of pro-urokinase.
    Ikeda Y; Ikata T; Mishiro T; Nakano S; Ikebe M; Yasuoka S
    J Med Invest; 2000 Feb; 47(1-2):61-75. PubMed ID: 10740981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cysteine protease inhibitor Ep-475 on TNF-alpha-independent cyclophosphamide-induced apoptosis in mouse lymphosarcoma LS cells.
    Zhanaeva SY; Korolenko TA; Khoshchenko OM; Spiridonov VK; Nikolin VP; Kaledin VI
    Bull Exp Biol Med; 2005 Feb; 139(2):186-9. PubMed ID: 16027802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of cell death in neuroblastoma by inhibition of cathepsins B and L.
    Colella R; Lu G; Glazewski L; Korant B; Matlapudi A; England MR; Craft C; Frantz CN; Mason RW
    Cancer Lett; 2010 Aug; 294(2):195-203. PubMed ID: 20362389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β signaling, activated stromal fibroblasts, and cysteine cathepsins B and L drive the invasive growth of human melanoma cells.
    Yin M; Soikkeli J; Jahkola T; Virolainen S; Saksela O; Hölttä E
    Am J Pathol; 2012 Dec; 181(6):2202-16. PubMed ID: 23063511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and discrimination of extracellularly active cathepsins B and L in high-invasive melanoma cells.
    Klose A; Zigrino P; Dennhöfer R; Mauch C; Hunzelmann N
    Anal Biochem; 2006 Jun; 353(1):57-62. PubMed ID: 16620747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progression.
    Bengsch F; Buck A; Günther SC; Seiz JR; Tacke M; Pfeifer D; von Elverfeldt D; Sevenich L; Hillebrand LE; Kern U; Sameni M; Peters C; Sloane BF; Reinheckel T
    Oncogene; 2014 Sep; 33(36):4474-84. PubMed ID: 24077280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective targeting of lysosomal cysteine proteases with radiolabeled electrophilic substrate analogs.
    Bogyo M; Verhelst S; Bellingard-Dubouchaud V; Toba S; Greenbaum D
    Chem Biol; 2000 Jan; 7(1):27-38. PubMed ID: 10662686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An activity-based probe for the determination of cysteine cathepsin protease activities in whole cells.
    Falgueyret JP; Black WC; Cromlish W; Desmarais S; Lamontagne S; Mellon C; Riendeau D; Rodan S; Tawa P; Wesolowski G; Bass KE; Venkatraman S; Percival MD
    Anal Biochem; 2004 Dec; 335(2):218-27. PubMed ID: 15556560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.